Revised international prognostic index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-Cell lymphoma (DLBCL) treated with rituximab and CHOP (R-CHOP).

被引：0
|
作者：
Sehn, LH
Chhanabhai, M
Fitzgerald, C
Gill, K
Hoskins, P
Klasa, R
Savage, K
Shenkier, T
Sutherland, J
Wilson, K
Gascoyne, RD
Connors, JM
机构：
[1] British Columbia Canc Agcy, Div Med Oncol, Vancouver, BC V5Z 4E6, Canada
[2] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada
[3] British Columbia Canc Agcy, Div Pathol, Vancouver, BC V5Z 4E6, Canada
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
492
引用
收藏
页码：147A / 147A
页数：1
相关论文
共 50 条
  • [1] The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP
    Sehn, Laurie H.
    Berry, Brian
    Chhanabhai, Mukesh
    Fitzgerald, Catherine
    Gill, Karamjit
    Hoskins, Paul
    Klasa, Richard
    Savage, Kerry J.
    Shenkier, Tamara
    Sutherland, Judy
    Gascoyne, Randy D.
    Connors, Joseph M.
    BLOOD, 2007, 109 (05) : 1857 - 1861
  • [2] International Prognostic Index (IPI) is a stronger predictor of outcome in diffuse large B cell lymphoma (DLBCL) treated with rituximab (R) and CHOP (R-CHOP) compared to revised-IPI (R-IPI)
    Soudy, H.
    Bakshi, N.
    Darwish, A.
    Salam, M. Abdel
    Rehman, A.
    Elhassan, T.
    Akhtar, S.
    Maghfoor, I.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S846 - S846
  • [3] LYMPHOCYTOPENIA MAY ADD TO THE PREDICTION ACHIEVED BY THE REVISED INTERNATIONAL PROGNOSTIC INDEX (R-IPI) IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) TREATED WITH RITUXIMAB-CHOP (R-CHOP)
    Vassilakopoulos, T.
    Anastasopoulou, A.
    Pangalis, G.
    Constantinou, N.
    Stavroulaki, E.
    Karakatsanis, S.
    Papageorgiou, S.
    Sachanas, S.
    Pappi, V.
    Tsirkinidis, P.
    Moschoyianni, M.
    Kyrtsonis, M.
    Kokoris, S.
    Kalpadakis, C.
    Siakantaris, M.
    Dimou, M.
    Georgiou, G.
    Konstantinidou, P.
    Dervenoulas, J.
    Roussou, P.
    Papadaki, H.
    Panayiotidis, P.
    Beris, P.
    Angelopoulou, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 280 - 280
  • [4] R-IPI as a predictor of survival in patients with diffuse large cell B-cell lymphoma (DLBCL) treated with R-chop chemotherapy
    Siddiqui, M.
    Johnston, P. B.
    Micallef, I. N.
    Ansell, S. M.
    Colgan, J. P.
    Habermann, T. M.
    Inwards, D. J.
    Markovic, S. N.
    Ristow, K.
    Witzig, T. E.
    Porrata, L. F.
    ANNALS OF ONCOLOGY, 2008, 19 : 146 - 146
  • [5] RITUXIMAB-CHOP (R-CHOP) IN THE TREATMENT OF 441 DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS: OUTCOME AND PROGNOSTIC FACTORS FOCUSING TO THE REVISED INTERNATIONAL PROGNOSTIC INDEX (R-IPI)
    Vassilakopoulos, T. P.
    Pangalis, G. A.
    Anastasopoulou, A.
    Angelopoulou, M. K.
    Dimou, M.
    Stavroulaki, E.
    Karakatsanis, S.
    Kalpadakis, C.
    Sachanas, S.
    Kyrtsonis, M. C.
    Kokoris, S. I.
    Siakantaris, M. P.
    Yiakoumis, X.
    Roussou, P.
    Panayiotidis, P.
    Papadaki, H.
    Constantinou, N.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 163 - 164
  • [6] IPI and R-IPI in Korean DLBCL patients treated with R-CHOP
    Bae, Sung-Hwa
    Ryoo, Hun-Mo
    Kim, Min Kyoung
    Lee, Kyung Hee
    Hyun, Myung Soo
    Kim, Hawk
    Park, Jea-Hoo
    Lee, Won-Sik
    Joo, Young-Don
    BLOOD, 2007, 110 (11) : 191B - 191B
  • [7] MYC and BCL-2 adjusted-International Prognostic Index (A-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP
    Wang, Jing
    Zhou, Min
    Xu, Jing-Yan
    Yang, Yong-Gong
    Zhang, Qi-Guo
    Zhou, Rong-Fu
    Chen, Bing
    Ouyang, Jian
    Li, Cuiping
    HISTOLOGY AND HISTOPATHOLOGY, 2016, 31 (03) : 285 - 292
  • [8] Addition of Absolute Lymphocytes/Monocytes Ratio Improves the Revised-International Prognostic Index (R-IPI) in Patients with Diffuse Large B Cell Lymphoma (DLBCL) Treated with R-CHOP
    Bento, Leyre
    Maria Bautista-Gili, Antonia
    Garcia, Francesc
    Martinez-Serra, Jordi
    Garcia-Mano, Lucia
    Garcia-Redo, Marta
    Ballester, Carmen
    Gines, Jordi
    Lopez, Paloma
    Daumal, Jaime
    Ramos, Rafael
    Salar, Antonio
    Sampol, Antonia
    Besalduch, Juan
    Gutierrez, Antonio
    BLOOD, 2015, 126 (23)
  • [9] Prognostic significance of international prognostic index (IPI) individual risk factors in patients with diffuse large b cell lymphoma (DLBCL) treated with rituximab (R) and chop (R-CHOP) based chemotherapy
    Akhtar, S.
    Soudy, H.
    Darwish, A.
    Salam, M. Abdel
    Elhassan, T.
    Rehman, A.
    Bakshi, N.
    Maghfoor, I.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S847 - S847
  • [10] REVISED INTERNATIONAL PROGNOSTIC INDEX (R-IPI): A NEW PROGNOSTIC MODEL FOR DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS
    Gimeno, E.
    Gimenez, T.
    Garcia-Pallerols, F.
    Alvarez-Larran, A.
    Sanchez-Gonzalez, B.
    Pedro, C.
    Abella, E.
    Saumell, S.
    Angona, A.
    Garcia, M.
    Besses, C.
    Salar, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 621 - 622
12345